CXCL10 and neoplasm: IFNγ has also been shown to induce the production of CXCL9 and CXCL10, which can aid in tumor rejection through the recruitment of activated CD8+ T cells and IFNγ-secreting Th1 cells to the primary tumor sites (26–28).